Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new treatment for people with type 2 diabetes mellitus (HSC R&D Co-Funding for JDRF)

Project: Research

Project Details

StatusActive
Effective start/end date1/01/2431/12/26

Funding

  • Health and Social Care R&D Division of the Public Health Agency for Northern Ireland: £89,959.00